Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Looking for participantsNCT03556228What this trial is testingVMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaWho this might be right forHead and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more VM Oncology, LLC 242
Large-scale testing (Phase 3)UnknownNCT00955695What this trial is testingRadiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung CancerWho this might be right forLung Cancer National Cancer Center, Korea 242
Not applicableStudy completedNCT02910999What this trial is testingReal-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior ChemotherapyWho this might be right forNon-Small Cell Lung Cancer Bristol-Myers Squibb 868
Testing effectiveness (Phase 2)Study completedNCT00783705What this trial is testingInositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial DysplasiaWho this might be right forNon-small Cell Lung CancerSquamous Lung Dysplasia National Cancer Institute (NCI) 85
Large-scale testing (Phase 3)Ended earlyNCT02162537What this trial is testingTherapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain MetastasesWho this might be right forNon-small Cell Lung Cancer MetastaticNon-small Cell Lung CancerAdenocarcinoma of Lung Metastatic to Brain+1 more Centre Hospitalier Intercommunal Creteil 95
Not applicableStudy completedNCT00963911What this trial is testingValidation of a Screening Tool in Geriatric OncologyWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+3 more Institut Bergonié 1,674
Testing effectiveness (Phase 2)Study completedNCT03526900What this trial is testingAtezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain MetastasisWho this might be right forNon-small Cell Lung Cancer Stage IV Spanish Lung Cancer Group 40
Testing effectiveness (Phase 2)Ended earlyNCT05245071What this trial is testingTusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEAWho this might be right forNon-squamous Non-small Cell Lung Cancer Sanofi 22
Early research (Phase 1)Ended earlyNCT00901537What this trial is testingAzacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck CancerWho this might be right forNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck Loma Linda University 8
Early research (Phase 1)Active Not RecruitingNCT06147037What this trial is testingA Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid TumoursWho this might be right forAdvanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more AstraZeneca 13
Testing effectiveness (Phase 2)UnknownNCT05338619What this trial is testingLazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation TherapyWho this might be right forNon-small Cell Lung Cancer Stage IIIEGFR Positive Non-small Cell Lung CancerNon-squamous Non-small-cell Lung Cancer Sung Yong Lee 77
Large-scale testing (Phase 3)Study completedNCT03676192What this trial is testingTo Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung CancerWho this might be right forAdenocarcinoma of Lung Celltrion 689
Large-scale testing (Phase 3)Study completedNCT02027428What this trial is testingSafety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung CancerWho this might be right forSquamous Cell Carcinoma, Non-Small-Cell Lung Celgene 427
Early research (Phase 1)UnknownNCT05780307What this trial is testingIMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorNon-small Cell Lung CancerSmall Cell Lung Cancer+3 more ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 48
Not applicableStudy completedNCT01333007What this trial is testingAn Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic or Recurrent Non-Squamous Non-Small Cell Lung CancerWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 423
Not applicableUnknownNCT04034667What this trial is testingStudy of CT and MR in the Lung CancerWho this might be right forLung Cancer Squamous CellCTGenes+2 more Henan Cancer Hospital 400
Early research (Phase 1)Ended earlyNCT04000529What this trial is testingPhase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected MalignanciesWho this might be right forNon-small Cell Lung CarcinomaHead and Neck Squamous Cell CarcinomaEsophageal SCC+2 more Novartis Pharmaceuticals 122
Testing effectiveness (Phase 2)Active Not RecruitingNCT04625647What this trial is testingTesting the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)Who this might be right forLung AdenocarcinomaLung Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell Carcinoma+3 more SWOG Cancer Research Network 116
Not applicableEnded earlyNCT01990261What this trial is testingAssess the Survival of Non-small Cell Lung Cancer Patients Treated With Tarceva After Failed Chemotherapy TreatmentWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 33